Chen P, Li Y, Jing X, Chen J, et al. Cost-effectiveness analysis of sugemalimab in combination with chemotherapy as first-line treatment in Chinese patients with metastatic NSCLC. Lung Cancer 2022;174:157-164.
PMID: 36413882